Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-624-3 | CAS number: 108-87-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study. Lack of details on test material (analytical purity), no data on GLP. Refer to endpoint summary Acute toxicity and IUCLID Section 13 for reporting and justification of the analogue approach.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
- Reference Type:
- secondary source
- Title:
- European Union Risk Assessment Report: Cyclohexane; CAS No: 110-82-7; EINECS No: 203-806-2
- Author:
- EUROPEAN COMMISSION - European Chemicals Bureau
- Year:
- 2 004
- Bibliographic source:
- European Chemical Bureau - Institute for Health and Consumer Protection
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- lack of details on test material (analytical purity)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Cyclohexane
- EC Number:
- 203-806-2
- EC Name:
- Cyclohexane
- Cas Number:
- 110-82-7
- IUPAC Name:
- cyclohexane
- Details on test material:
- - Name of test material (as cited in study report): Cyclohexane
- Molecular formula: C6H12
- Molecular weight: 84.16
- Smiles notation: C1CCCCC1
- InChl: 1S/C6H12/c1-2-4-6-5-3-1/h1-6H2
- Analytical purity: no data
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Laboratory Animals, Inc.
- Age at study initiation: young adults
- Weight at study initiation: 2645-3125 g (males); 2640-3000 g (females)
- Housing: individual
- Diet: Purina Lab Rabbit Chow(R), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2
- Humidity (%): 40-60
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: the test material was applied to the shaved back.
- % coverage: 10
- Type of wrap if used: the test material was held in contact with the skin by means of a non-absorbent binder.
REMOVAL OF TEST SUBSTANCE
- Washing: the exposed area was wiped (but not washed) to remove any test material remaining.
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied: ca. 6.86-8.12 mL (as calculated from the reported body weight data and a density of 0.77 g/cm³ (EC –ECB, 2004)
- Constant volume or concentration used: no - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: mortality and gross pharmacological and toxicological signs were recorded immediately after dosing, at 1 and 4 h, and twice daily thereafter. Individual body weights were recorded just prior to initiation and on Days 7 and 14. Skin sites were evaluated for signs of irritation on Days 1, 3, 7, 10 and 14 according to the Draize scoring system.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross necropsy, skin irritation scoring.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred among the test animals during the study.
- Clinical signs:
- other: With the exception of phonation upon application, all rabbits appeared normal throughout the study.
- Gross pathology:
- No observable gross pathology findings were noted in any of the rabbits upon necropsy.
- Other findings:
- Erythema on Day 1 ranged from very slight in 2 males and 2 females to well-defined in 1 female. Erythema on Day3 was noted as very slight in 2 males and 2 females and had cleared by Day 7.
Edema on Day 1 ranged from very slight in 1 male and 3 females to slight in 1 male and cleared by Day 3. Epidermal scaling was noted in 1 female on Day 10. Refer to Table 1.
Any other information on results incl. tables
Table 1. Individual dermal irritation scores
Animal No. |
Erythema score |
Edema score |
||||||||
Day |
Day |
|||||||||
1 |
3 |
7 |
10 |
14 |
1 |
3 |
7 |
10 |
14 |
|
Males |
||||||||||
1 |
1 |
1 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
Females |
||||||||||
1 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
2* |
2 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
3 |
1 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
* This animal showed epidermal scaling on Day 10.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Cyclohexane was tested for acute dermal toxicity in rabbits (3 males and 3 females) in a study conducted following a protocol equivalent to OECD 402. The test substance was applied at 2000 mg/kg bw to an area of shaved dry skin covering approx. 10% of the total body surface, and held in contact with the skin for 24 h. Animals were observed for mortality and clinical signs for a period of 14 days following application. Body weights were determined weekly and skin reactions were evaluated according to the Draize scoring system 24 and 72 h and 7, 10 and 14 days post-application. No mortality occurred and the only clinical sign reported was phonation upon application. Animals showed normal body weight development and necropsy revealed no treatment-related changes. In 5/6 animals, very slight to slight erythema was observed at the 24 and 72 h reading time points, and very slight to slight edema was seen only at 24 h. Skin redness was fully reversible within 7 days post-application. One animal showed epidermal scaling on Day 10. Based on the study results, the dermal LD50 in male and female rabbits is greater than 2000 mg/kg bw.
In this study, no mortality and no signs of systemic toxicity were observed. Therefore, the results do not fulfil the classification criteria for acute toxicity by the dermal route according to Regulation (EC) No 1272/2008 and Directive 67/548/EEC.
CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.